S. No. |
Class |
Drug (Active Ingredient) |
Company |
Remarks |
1 |
NRTI |
Zidovudine (AZT)* |
Ranbaxy (Sirmour, Himachal Pradesh), Aurobindo (Hyderabad, Andhra Pradesh), Cipla (Verna Industrial Estate, Goa), Matrix Laboratories (Nashik, Maharashtra), Hetero Drugs (Hyderabad, Andhra Pradesh) |
Second Line |
2 |
NRTI |
Lamivudine (3TC) #
|
Ranbaxy (Sirmour, Himachal Pradesh), Cipla Limited (Verna Industrial Estate, Goa), Matrix Laboratories (Nashik, Maharashtra), Hetero Drugs (Hyderabad, Andhra Pradesh), Macleods Pharmaceuticals (Kachigam,Daman) |
Second Line |
3 |
NRTI |
Stavudin (d4T)* |
Aurobindo (Hyderabad, Andhra Pradesh), Matrix Laboratories (Nashik, Maharashtra), Cipla (Verna Industrial Estate, Goa), Emcure Pharmaceuticals (Pune, Maharashtra), Hetero Drugs (Hyderabad, Andhra Pradesh) |
- |
4 |
NRTI |
Didanosine (ddl)* |
Aurobindo (Hyderabad, Andhra Pradesh) |
Second Line |
5 |
NRTI |
Abacavir sulfate (ABC) #
|
Aurobindo (Hyderabad, Andhra Pradesh), Matrix Laboratories (Nashik, Maharashtra) |
Second Line |
6 |
NRTI |
Emtricitabine (FTC) #
|
Aurbindo (Hyderabad, Andhra Pradesh), Matrix Laboratories (Nashik, Maharashtra) |
- |
7 |
NRTI |
Tenofovir disoproxil fumarate (TDF) #
|
Matrix Laboratories (Nashik, Maharashtra) |
Second Line |
8 |
NRTI |
Abacavir, zidovudine, and lamivudine (ABC, AZT and 3TC) #
|
Aurbindo (Hyderabad, Andhra Pradesh) |
3NRTI; Trizivir US brand name in Indian generic FDC manufactured; First Line |
9 |
NRTI |
Lamivudine and zidovudine (3TC and AZT) #
|
Aurobindo (Hyderabad, Andhra Pradesh), Pharmacare Ltd, Cipla (Verna Industrial Estate, Goa), Emcure Pharmaceuticals Limited (Pune, Maharashtra), Matrix Laboratories (Nashik, Maharashtra), Hetero Drugs (Hyderabad, Andhra Pradesh) |
2 NRTI; Combivir US brand name in Indian generic FDC manufactured; First Line |
10 |
NRTI |
Abacavir and lamivudine (ABC and 3TC) #
|
Aurobindo (Hyderabad, Andhra Pradesh) |
2 NRTI; Epzicom US brand name in Indian generic FDC manufactured |
11 |
NRTI |
Tenofovir disoproxil fumarate and emtricitabine (TDF and FTC) #
|
Matrix Laboratories (Nashik, Maharashtra), Aurobindo (Hyderabad, Andhra Pradesh) |
2 NRTI; Truvada US brand name in Indian generic FDC manufactured; Second Line |
12 |
2 NRTI |
Lamivudine+Tenofovir Disoproxil Fumarate #
|
Matrix Laboratories (Nashik, Maharashtra) |
- |
13 |
2 NRTI |
Abacavir Sulfate+Lamivudine #
|
Aurobindo (Hyderabad, Andhra Pradesh) |
|
14 |
3 NRTI |
Lamivudine+Zidovudine+Abacavir Sulfate #
|
Aurbindo (Hyderabad, Andhra Pradesh) |
First Line |
15 |
NNRTI |
Nevirapine (NVP) #
|
Ranbaxy (Sirmour, Himachal Pradesh), Aurobindo (Hyderabad, Andhra Pradesh), Cipla (Verna Industrial Estate, Goa), Strides Arcolabs (Anekal Taluk Bangalore), Hetero Drugs (Hyderabad, Andhra Pradesh), Matrix Laboratories (Nashik, Maharashtra) |
First Line |
16 |
NNRTI |
Efavirenz (EFV) #
|
Aurobindo (Hyderabad, Andhra Pradesh), Cipla Limited (Verna Industrial Estate, Goa), Strides Arcolab (Anekal Taluk Bangalore), Matrix Laboratories (Nashik, Maharashtra), Emcure Pharmaceuticals (Pune, Maharashtra), Hetero Drugs (Hyderabad, Andhra Pradesh) |
First Line |
17 |
NNRTI |
Etravirine #
|
Johnson & Johnson |
204028; mail-box application no. IN/PCT/2001/00436/MUM |
18 |
NNRTI+NRTI |
Efavirenz, emtricitabine and tenofovir disoproxil fumarate (EFV, FTC and TDF) |
Viraday is manufactured by Cipla |
NNRTI+NRTI combination; Atripla US brand name in Indian generic FDC called viraday [2] |
19 |
2 NRTI+NNRTI |
Stavudine+Lamivudine+Efavirenz #
|
Strides Arcolab (Anekal Taluk Bangalore) |
First Line |
20 |
2 NRTI+NNRTI |
Lamivudine+Zidovudine+Efavirenz #
|
Strides Arcolab (Anekal Taluk Bangalore), Aurobindo (Hyderabad, Andhra Pradesh) |
First Line |
21 |
2 NRTI+NNRTI |
Lamivudine+Zidovudine+Nevirapine #
|
Aurobindo (Hyderabad, Andhra Pradesh), Cipla Limited (Verna Industrial Estate, Goa), Strides Arcolab (Anekal Taluk Bangalore) |
First Line |
22 |
2 NRTI+NNRTI |
Lamivudine+Stavudine+Nevirapine #
|
Strides Arcolab (Anekal Taluk Bangalore) |
First Line |
23 |
PI |
Indinavir (IDV) #
|
Cipla (Verna Industrial Estate, Goa), Emcure (Pune, Maharashtra), Hetero Drugs (Hyderabad, Andhra Pradesh), Ranbaxy (Sirmour, Himachal Pradesh) |
Second Line |
24 |
PI |
Nelfinavir (NFV) #
|
Cipla (Verna Industrial Estate, Goa), Hetero Drugs (Hyderabad, Andhra Pradesh), Macleods Pharmaceuticals (Kachigam,Daman) |
Second Line |
25 |
PI |
Ritonavir (RTV) #
|
Cipla (Verna Industrial Estate, Goa), Hetero Drugs (Hyderabad, Andhra Pradesh) |
Second Line |
26 |
PI |
Lopinavir/Ritonavir #
|
Matrix Laboratories (Nashik, Maharashtra), Aurobindo (Hyderabad, Andhra Pradesh), Cipla (Verna Industrial Estate, Goa) |
Second Line |
27 |
PI |
Atazanavir (ATV) #
|
Emcure Pharmaceuticals (Pune, Maharashtra) |
Second Line |
28 |
PI |
Darunavir**
|
Emcure Pharmaceuticals (Pune, Maharashtra) |
Second Line |
28 |
Fusion Inhibitor |
Nil |
|
Nil |
29 |
Entry Inhibitors-CCR5 co-receptor antagonist |
Maraviroc |
|
Patent granted in India;204132; mail-box Application No. 885/BOM/1999; Drug registration in process [1] Second Line |
30 |
HIV integrase strand transfer inhibitors |
Reltegravir Potassium |
|
Patent granted in India; 212400; mail-box application no. 868/CHENP/2004 |